|
Dear SPARTAN Community,
I am honored to introduce myself as the new Chair of the Spondyloarthritis Research and Treatment Network (SPARTAN). As reflected in our mission statement, our pillars continue to be advancement of research and education. Additionally, a new and evolving focus is support of junior SPARTAN members through targeted research grants and mentorship.
Research
Our research program is a mixture of major SPARTAN-led initiatives and a grants program supporting junior investigators. The CLASSIC study, an international effort to validate the ASAS 2009 classification criteria for axial SpA, completed enrolment in 2022; data from this study will be presented at the ACR 2024 Convergence, and much more data will be forthcoming. SPARTAN is also planning a biomarker study taking advantage of the infrastructure developed for CLASSIC. We also have several programs supporting junior investigators. These are the mentored fellowship award (a one year $10,000 award), the Early Career Investigator award ($25,000 / year x two years), and a new $100,000 Spondyloarthritis Research Fellowship generously supported by UCB that is targeted to junior members who need to reach out to different institutions to find spondyloarthritis mentorship. Additional grants targeting fellows and junior faculty are in the planning stages!
Education
SPARTAN’s education mission extends to all levels of learners. The SpA review course adjacent to the Annual Meeting, while developed for fellows, is a terrific review for learners at all levels. The SPARTAN GRAPPA ASAS symposium will once again be held at the conclusion of ACR Convergence on Tuesday, November 19 from 12:30 – 2:30 p.m. at the Marriott Marquis. We are also developing educational symposia around the world to enhance our international reputation and as well benefit patients and providers who may not otherwise have access to the latest information. Additional educational efforts are targeted towards our referring provider base. This includes the Early Identification and Diagnosis of Axial Spondyloarthritis (EIDA) program sponsored by Pfizer, through which we have given 54 talks to over 3000 audience members about the nature of axial SpA and as well upcoming publication of SPARTAN referral recommendations, a project led by Drs. Maureen Dubreuil and Abhijeet Danve, that aims to provide guidance on which adults with chronic back pain should be referred to rheumatology.
Mentorship
A new initiative introduced last summer on a trial basis is the SPARTAN Training and Mentorship Program (STAMP). A unique and significant feature of STAMP is the manual matching of prospective mentors and mentees based on shared interests, such as clinical trials, outcomes research, and basic science.
Networking
Every year, the feedback from the annual meeting includes requests for additional networking opportunities. We have taken a big step in that direction through development of the second annual SPARTAN Member Forum at ACR Convergence 2024, to be held Saturday November 16 at the Mariott Marquis from 5:30 – 7:30 PM. As part of the forum, we are introducing the Collaborator Connection, geared towards SPARTAN researchers who wish to introduce themselves to the community to meet potential collaborators.
Of course, our most important networking opportunity each year is the SPARTAN Annual Meeting. We are pleased to announce that the 2025 Annual Meeting will be held in Toronto, Canada at the Toronto Hilton Hotel May 9-10 , with the Spondyloarthritis Review Course as always being held the preceding day on Thursday, May 8).
Sponsors
Finally, none of this would be possible without the generous support of our sponsors. On behalf of SPARTAN, I wish to extend our heartfelt gratitude to our diamond sponsors AbbVie, Novartis, and UCB; our gold sponsor J&J Innovative Medicine; and our silver sponsors Lilly and Pfizer. Furthermore, several of our educational and research programs receive supplementary funding, and we extend our gratitude to our sponsors for this additional support.
In conclusion, I wish to thank all of you for your continued support and dedication to advancing the field of spondyloarthritis. I look forward to seeing you at the SPARTAN Member Forum in Washington DC and invite you to work with us to enhance our mission!
Regards, Matt
Matthew Stoll, MD, PhD, MSCS
Professor, Pediatric Rheumatology
University of Alabama at Birmingham
|